Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy LeMaitre Vascular (LMAT) stocks in Canada

Learn how to easily invest in LeMaitre Vascular stocks.

LeMaitre Vascular is a medical instruments & supplies business based in the US. LeMaitre Vascular stocks (LMAT.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $59.89 – a decrease of 1.25% over the previous week. LeMaitre Vascular employs 386 staff and has a trailing 12-month revenue of around $152.5 million.

How to buy shares in LeMaitre Vascular

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – LMAT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

LeMaitre Vascular stock price (NASDAQ:LMAT)

Use our graph to track the performance of LMAT stocks over time.

LeMaitre Vascular shares at a glance

Information last updated 2022-01-25.
Latest market close$42.83
52-week range$41.68 - $64.23
50-day moving average $49.02
200-day moving average $53.31
Wall St. target price$65.86
PE ratio 33.243
Dividend yield $0.425 (1%)
Earnings per share (TTM) $1.33

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy LeMaitre Vascular stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

LeMaitre Vascular price performance over time

Historical closes compared with the close of $42.83 from 2022-01-25

1 week (2022-01-15) N/A
1 month (2021-12-23) -16.90%
3 months (2021-10-26) -22.35%
6 months (2021-07-26) -21.50%
1 year (2021-01-26) -10.02%
2 years (2020-01-24) 17.41%
3 years (2019-01-25) 82.49%
5 years (2017-01-26) 85.09%

Is LeMaitre Vascular under- or over-valued?

Valuing LeMaitre Vascular stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of LeMaitre Vascular's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

LeMaitre Vascular's P/E ratio

LeMaitre Vascular's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 33x. In other words, LeMaitre Vascular shares trade at around 33x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

LeMaitre Vascular's PEG ratio

LeMaitre Vascular's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.005. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into LeMaitre Vascular's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

LeMaitre Vascular's EBITDA

LeMaitre Vascular's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $48.4 million.

The EBITDA is a measure of a LeMaitre Vascular's overall financial performance and is widely used to measure a its profitability.

LeMaitre Vascular financials

Revenue TTM $152.5 million
Operating margin TTM 24.71%
Gross profit TTM $84.6 million
Return on assets TTM 8.55%
Return on equity TTM 13.54%
Profit margin 18.21%
Book value $11.40
Market capitalisation $964.8 million

TTM: trailing 12 months

LeMaitre Vascular share dividends

33%

Dividend payout ratio: 33.33% of net profits

Recently LeMaitre Vascular has paid out, on average, around 33.33% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), LeMaitre Vascular shareholders could enjoy a 1% return on their shares, in the form of dividend payments. In LeMaitre Vascular's case, that would currently equate to about $0.425 per share.

While LeMaitre Vascular's payout ratio might seem fairly standard, it's worth remembering that LeMaitre Vascular may be investing much of the rest of its net profits in future growth.

LeMaitre Vascular's most recent dividend payout was on 1 December 2021. The latest dividend was paid out to all shareholders who bought their shares by 17 November 2021 (the "ex-dividend date").

LeMaitre Vascular share price volatility

Over the last 12 months, LeMaitre Vascular's shares have ranged in value from as little as $41.68 up to $64.2341. A popular way to gauge a stock's volatility is its "beta".

LMAT.US volatility(beta: 1.31)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while LeMaitre Vascular's is 1.3147. This would suggest that LeMaitre Vascular's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

LeMaitre Vascular overview

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; powered phlebectomy devices to remove varicose veins; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers remote endarterectomy devices to remove plaque from arteries in the leg; valvulotomes, which cut valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular patches, which are used for closure of vessels after surgical intervention; closure systems to attach vessels to one another with titanium clips instead of sutures; and surgical glue. It markets its products through a direct sales force and distributors.

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site